is a TNF blocker. It is used to treat inflammation in Crohn’s disease. In Crohn’s disease the digestive tract becomes inflamed and adversely affects the gastrointestinal tract. It is also used to reduce or prevent inflammation in rheumatoid arthritis. It blocks TNF and reduces or prevents destruction of joints. Cimzia was approved in April 2008 by U.S. Food and Drug Administration. It is being investigated for the potential risk of cancer as well as the risk of developing life-threatening infections.

Previous ArticleMedical Use of Cimzia Next ArticleThe FDAs Many Updates Regarding Actos
Verdicts and Settlements
Newsletter
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers